Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison

[1]  P. Touboul,et al.  A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects , 2007, The Lancet Neurology.

[2]  P. Rothwell,et al.  Substantial underestimation of the need for outpatient services for TIA and minor stroke. , 2007, Age and ageing.

[3]  A. Demchuk,et al.  Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial , 2007, The Lancet Neurology.

[4]  J. Spence,et al.  Combining Multiple Approaches for the Secondary Prevention of Vascular Events After Stroke: A Quantitative Modeling Study , 2007, Stroke.

[5]  Paul Glasziou,et al.  When are randomised trials unnecessary? Picking signal from noise , 2007, BMJ : British Medical Journal.

[6]  S Claiborne Johnston,et al.  Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack , 2007, The Lancet.

[7]  G. Tsivgoulis,et al.  Validation of the ABCD Score in Identifying Individuals at High Early Risk of Stroke After a Transient Ischemic Attack: A Hospital-Based Case Series Study , 2006, Stroke.

[8]  M. Potts,et al.  Parachute approach to evidence based medicine , 2006, BMJ : British Medical Journal.

[9]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[10]  M. Simoons,et al.  Quality of Hospital and Outpatient Care After Stroke or Transient Ischemic Attack: Insights From a Stroke Survey in The Netherlands , 2006, Stroke.

[11]  S. Kasner,et al.  Is the ABCD Score Useful for Risk Stratification of Patients With Acute Transient Ischemic Attack? , 2006, Stroke.

[12]  A. Algra,et al.  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial , 2006, The Lancet.

[13]  P. Rothwell,et al.  Patient Behavior Immediately After Transient Ischemic Attack According to Clinical Characteristics, Perception of the Event, and Predicted Risk of Stroke , 2006, Stroke.

[14]  S Claiborne Johnston,et al.  Recent advances in management of transient ischaemic attacks and minor ischaemic strokes , 2006, The Lancet Neurology.

[15]  M. Correia,et al.  Transient Ischemic Attacks in Rural and Urban Northern Portugal: Incidence and Short-Term Prognosis , 2006, Stroke.

[16]  S. Gutnikov,et al.  Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) , 2005, The Lancet.

[17]  P. Rothwell,et al.  A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack , 2005, The Lancet.

[18]  E. Ringelstein,et al.  Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial , 2005, Circulation.

[19]  J. Broderick,et al.  Incidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study , 2005, Stroke.

[20]  P. Rothwell,et al.  Timing of TIAs preceding stroke , 2005, Neurology.

[21]  P. Rothwell,et al.  External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.

[22]  P. Griffiths,et al.  Is the rapid assessment stroke clinic rapid enough in assessing transient ischaemic attack and minor stroke? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[23]  S. Gutnikov,et al.  Sex Difference in the Effect of Time From Symptoms to Surgery on Benefit From Carotid Endarterectomy for Transient Ischemic Attack and Nondisabling Stroke , 2004, Stroke.

[24]  J. Saver,et al.  In-Hospital Initiation of Secondary Stroke Prevention Therapies Yields High Rates of Adherence at Follow-up , 2004, Stroke.

[25]  P. Heuschmann,et al.  Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. , 2004, JAMA.

[26]  P. Rothwell,et al.  Direct Assessment of Completeness of Ascertainment in a Stroke Incidence Study , 2004, Stroke.

[27]  P. Rothwell,et al.  Underestimation of the Early Risk of Recurrent Stroke: Evidence of the Need for a Standard Definition , 2004, Stroke.

[28]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[29]  S. Gutnikov,et al.  Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study) , 2004, The Lancet.

[30]  Jan P Vandenbroucke,et al.  When are observational studies as credible as randomised trials? , 2004, The Lancet.

[31]  A. Laupacis,et al.  Management and outcomes of transient ischemic attacks in Ontario , 2004, Canadian Medical Association Journal.

[32]  M. Eliasziw,et al.  Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery , 2004, The Lancet.

[33]  P. Rothwell,et al.  Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services , 2004, BMJ : British Medical Journal.

[34]  P. Sandercock,et al.  Very Early Risk of Stroke After a First Transient Ischemic Attack , 2003, Stroke.

[35]  H. Diener,et al.  The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors , 2003, Stroke.

[36]  D. Hanley,et al.  Prevalence and knowledge of transient ischemic attack among US adults , 2003, Neurology.

[37]  S. Gutnikov,et al.  Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis , 2003, The Lancet.

[38]  P. Rothwell,et al.  High early risk of stroke after a first transient ischaemic attack , 2003 .

[39]  S. Majumdar,et al.  How Well Are Hypertension, Hyperlipidemia, Diabetes, and Smoking Managed After a Stroke or Transient Ischemic Attack? , 2002, Stroke.

[40]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[41]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[42]  M. Woodward,et al.  Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .

[43]  D. Johnston.  Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack , 2001, The Lancet.

[44]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[45]  Michael F. Oliver,et al.  Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. , 2001, Indian heart journal.

[46]  Thompson G. Robinson,et al.  National Clinical Guidelines for Stroke. , 2001 .

[47]  S. Gutnikov,et al.  A pooled analysis of individual patient data from trials of endarterectomy for symptomatic carotid stenosis: efficacy of surgery in important subgroups , 2001 .

[48]  S. Sidney,et al.  Short-term prognosis after emergency department diagnosis of TIA. , 2000, JAMA.

[49]  G. Samsa,et al.  New transient ischemic attack and stroke: outpatient management by primary care physicians. , 2000, Archives of internal medicine.

[50]  J. Concato,et al.  Randomized, controlled trials, observational studies, and the hierarchy of research designs. , 2000, The New England journal of medicine.

[51]  Wade S. Smith,et al.  Practice Variability in Management of Transient Ischemic Attacks , 1999, European Neurology.

[52]  C Bain,et al.  Interpreting the evidence: choosing between randomised and non-randomised studies , 1999, BMJ.

[53]  S. Phillips,et al.  What is the Cost of Admitting Patients with Transient Ischaemic Attacks to Hospital? , 1999, Cerebrovascular Diseases.

[54]  Zheng-Ming Chen,et al.  CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke , 1997, The Lancet.

[55]  Peter Sandercock,et al.  The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke , 1997, The Lancet.

[56]  M. Dennis.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee , 1996 .

[57]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[58]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[59]  Leandro Provinciali,et al.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke , 1993 .

[60]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[61]  T C Chalmers,et al.  Randomized versus historical controls for clinical trials. , 1982, The American journal of medicine.